Background: Genetic variants (MTTP, TM6SF2, FABP1) that modulate hepatic steatosis are linked to increased hepatocellular carcinoma (HCC). Liver specific deletion of Mttp (Mttp-LKO) or Tms6sf2 increase fibrosis, steatosis and HCC, while Dgat2-LKO mice show decreased steatosis but not fibrosis…